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Background and Objective: Aminolevulinic acid photo-
dynamic therapy (ALA-PDT) depends on drug metabolism
into porphyrins. Clinically, ALA-PDT has been used with a
wide range of protocols for treating both epidermal and
dermal targets, despite limitedunderstanding of porphyrin
biodistribution over time. We studied porphyrin accumu-
lation after topical application of ALA in vivo, and also
describe the porcine ear as a new animal model to study
adnexal glands.
Study Design/Materials and Methods: The microana-
tomy of anterior ear skin of swine was measured. Topical
20% ALA in water/ethanol was applied under occlusion.
Biopsies taken after 5, 10, 15, and then every 15minutes for
a total of 3hourswere examinedbyfluorescencemicroscopy
of frozen sections toassess accumulationanddistribution of
porphyrins.
Results: Porphyrin fluorescence of digital photomicro-
graph images was not visually apparent until 30–
45 minutes after application, although quantitative pixel
analysis showed a statistically significant increase in
epidermal fluorescence only 15 minutes after ALA applica-
tion. From 30 to 120 minutes, epidermis, hair follicles
(HF), and sebaceous glands (SG) became progressively
more fluorescent. Eccrine gland fluorescence began to be
detected after 30minutes; SG showed fluorescence starting
at 45–75 minutes. Fluorescence in all sites reached
maximum intensity from 75 to 180 minutes of incubation.
There was a trend for HF and SG to express stronger
fluorescence compared with epidermis and eccrine glands.
Conclusion: Anterior pig ear skin is microanatomically
similar to human sebaceous skin. The time-dependent
accumulation of porphyrins in pilosebaceous units and
eccrine glands in thismodel suggests other routes of uptake
of topical ALA in addition to the trans-epidermal
route. Apparently, time interval between ALA application
and light exposure could be optimized for different uses of
ALA-PDT. Lasers Surg. Med. 41:154–160, 2009.
 2009 Wiley-Liss, Inc.
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INTRODUCTION
Acnevulgaris is themost commonskin disease [1–3], and
the most common cause of permanent facial scarring.
Pathogenesis includes hyperkeratinization with plugging
of the pilosebaceous unit, excessive production of sebum,
hormonal changes, bacterial colonization, and inflamma-
tory and immunological changes. Conventional topical
treatments include antibiotics, retinoids, benzoyl peroxide,
and salicylic acid. These topical acne treatments affect
bacteria, hyperkeratinization, plugging, and inflamma-
tion.
Conventional systemic treatments include oral anti-
biotics, birth control pills, and oral retinoids. Oral iso-
tretinoin in the most effective therapy for acne vulgaris,
and the only one that directly inhibits sebaceous gland (SG)
activity. Unfortunately, oral isotretinoin causes major side
effects, including fetal malformations when taken during
pregnancy. Topical photodynamic therapy (PDT) is a
promising alternative for acne treatment, which like oral
isotretinoin can directly inhibit SG function [4].
PDT is a powerful therapeutic method that combines
delivery of a photosensitizer (PS) or PS precursor followed
by light exposure that activates the PS to produce reactive
oxygen species (ROS), which act as intermediates that
locally affect the tissue. Cytotoxicity produced by ROS is
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usually located at the site where the PS is accumulated,
such that selective targeting of microscopic tissue struc-
tures is possible if the PS is localized. 5-Aminolevulinic acid
(ALA) is a natural PS precursor, found in all human cells as
part of the heme synthesis pathway [5]. When exogenously
applied, ALA overdrives the pathway, producing porphyr-
ins, the active PS. Because aminolevulinic acid photo-
dynamic therapy (ALA-PDT) depends on drug delivery
followed bymetabolism into porphyrins, the distribution of
PS within tissue varies with time after ALA administra-
tion, route of administration, and any factor that affects
ALA metabolism.
ALA-PDThasbeendescribed for the treatment of various
skin problems, including actinic keratoses [6], superficial
skin cancers [7], psoriasis [8], warts [9], cutaneous T-cell
lymphoma [10], acne [4], and cosmetic rejuvenation [11].
Topical 20% ALA (water/alcohol) solution for 12 hours
followed by blue light exposure is currently FDA approved
and commercially available in the US as a treatment for
actinic keratosis, but in practice a wide range of
application times and light sources are used. Methyl-ester
of ALA is also used in Europe in similar fashion. For acne
treatment, different protocols have been reported with
variable clinical responses to ALA-PDT. A wide variety of
blue, yellow or red lamps, LED sources and lasers have
been used for ALA-PDT of acne. The time of incubation,
measured from when the drug is applied until the
activating light is given, has varied from 15 minutes [12]
to 4 hours [13]. Despite clinical exploration of topical ALA-
PDT for acne treatment under a wide variety of conditions,
little is known about the kinetics and distribution of PS
induced in sebaceous skin after topical ALA. We decided to
study this in porcine sebaceous skin.
There is no ideal animal model for the study of acne.
Animal models include the rabbit ear [14–16], Mexican
hairless dog [17], rhino mouse [18], rat ear [18,19], and
Syrian hamster flank organ [20], none of which simulate
exactly the anatomical and physiological conditions
involved in human acne. For studies of a topical agent such
as ALA, penetration of the agent is affected by the stratum
corneum and by density of hair follicles (HF). Rodent and
furred animal models do not mimic human skin well in
these regards. Pigs are well known to be a good cutaneous
animal model, as they are non-furred, non-rodent
animals with skin that resembles non-sebaceous human
skin anatomically and physiologically [21–23]. Porcine
skin has already been shown to be a good animal model for
ALA-PDT studies in vivo [24]. Similar to humans, pigs are
proven to metabolize ALA into porphyrins that can be
directly measured (by porphyrin extraction) and/ or
indirectly analyzed (e.g., by fluorescence photography or
spectrofluorimeter measurements). However, the very
small SG of swine skin are a major limitation to the use of
this model for photodynamic studies related to sebaceous
follicles. SG secretewax esters, and tend to be prominent in
mammalian ear skin. We therefore examined pig ears,
found an abundance of large SG similar to those in human
sebaceous skin, and performed a study of the kinetics and
distribution of porphyrins synthesized from topical ALA.
MATERIALS AND METHODS
Defining an Animal Model to Study Adnexal
Glands and Porphyrin Metabolism
The anterior (inner) ear skin of two female
adult Yucatan mini-pigs (retired breeders) (about 120 kg)
and of three young female Yorkshire pigs (about 30–50 kg)
were harvested for microanatomy analysis. Different
types of pigs were used to verify the existence of same
skin structures in these different breeds. Six random
biopsies (4-mm punch) from the anterior of each animal’s
ear (helix and lobule) were examined after H&E
staining under light microscopy. The thickness of epider-
mis, size, and depth of HF, SG, and eccrine/apocrine
glands (EG) were measured. Depth of the follicles and
glands was measured relative to the bottom of the
epidermis. For epidermis, relative maximum and mini-
mum thickness were measured. For HF, SG, and EG the
two maximum axial diameters were measured, and
averaged. For comparison with human facial skin, three
discarded preauricular skin samples from face lifts in adult
females were processed and analyzed similarly, in addition
to comparison with published microanatomy studies of
human skin. These non-identifiable skin specimens had
MGH Institutional Review Board approval to be used in
this research.
Porphyrin Production After Topical Application
of 20% ALA In Vivo
Animals. Three female domestic Yorkshire swine
weighing 30–50 kg were used in the study, which was
approved by the MGH Institutional Subcommittee for
Research Animal Care. Animals were anesthetized
with intramuscular (IM) Telazol/Xylazine (4.4 and
2.2 mg/kg) and inhaled Isoflurane 2.0% with 3.0 L/min in
oxygen after fasting overnight. Temperature-controlled
blankets were used under the animals to maintain core
temperature while under anesthesia. Euthanasia was
performed with pentobarbital 100 mg/kg IV while under
anesthesia.
ALA solutions. 5-ALA hydrochloride from Biosynth
International, Inc. (Naperville, IL) was prepared as a 20%
solution in equal parts of ethanol/water for topical
application of 0.5 cm3 per 10 cm2 skin area. After ALA
administration, the skinwas occludedwith plastic sheeting
(Saran wrap) and covered with aluminum foil, to avoid
ambient light exposure during the experiment.
Study design. Each animal’s inner ears were cleansed
with isopropanol, rinsed with water, clipped of hair,
cleansed and rinsed again, dried with a towel. The drug
was homogeneously applied onto the skin test sites (both
ears of each animal), then occluded with Saran plastic
wrap. Control sites were also occluded, but received no
topical application. Biopsies for fluorescence microscopy
were taken at baseline and after 5, 10, and 15 minutes
of drug application; and then every 15 minutes for a total
of 3 hours after ALA application. Four millimeter punch
biopsies were separated from each other by at least 0.5 cm.
Each biopsy site was kept occluded until immediately
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before the biopsy, which took less than 1 minute, and
covered immediately after the procedure.
Fluorescence microscopy. For each time after ALA
application, two biopsies were taken and prepared as a
fresh-frozen specimen for analysis by fluorescence micro-
scopy. Biopsies were also taken and processed from the
control sites. Frozen sections (15 mm thick) were made
using a cryostat (Leica CM 1510S-3, Leica Microsystems
NusslockGmbH,Nussloch,Germany).Digital fluorescence
photo-microscopy was performed using a Nikon Eclipse TE
2000-S (Tokyo, Japan) at 10 magnification, with 415 nm
excitation and 635 nm emission band-pass filters. Images
were captured using a light CCD camera (RT3TM slider,
Diagnostic Instruments, Inc., Sterling Heights, MI) with-
out automatic gain control or other signal processing, and
analyzed using software (SpotTM software, Diagnostic
Instruments, inc.). For each biopsy, a series of two to four
representative frozen sections containing at least one skin
structure (epidermis, HF, SG, and sweat glands) was
analyzed, including at least two slides containing each
skin structure for each time of sampling. The photo-
micrography settings during fluorescence microscopy were
manually set and kept the same for all samples (10 seconds
of integration time), which were analyzed under low light
conditions to minimize porphyrin photobleaching, and as a
batch to minimize long-term instability of the microscopy
source. For each batch, the excitation light was stable
during the photograph acquisition, at an intensity of
6.5 mW/cm2.
Direct fluorescence assessment through the microscope
was avoided to minimize porphyrins photobleaching
during the light excitation; therefore, the analysis of
fluorescence was performed using the digitally acquired
images only.
Image analysis. Experiment and control frozen section
slideswere transformed intomicroscopic fluorescent photo-
graphs at 10. In each of those photographs, four 5050
pixel square regions of interest (ROI) corresponding to
100 mm100 mm of tissue, were extracted from epidermis,
HFepithelium,SG,EG, dermis, andbackground (no tissue)
for analysis. The ROI of each skin structure were randomly
chosen sites that included as fully as possible the structure
of interest. For HF, SG and epidermis, hair shafts, and
stratum corneum were excluded from ROI to minimize
errors due to the noted autofluorescence. Size of the ROI
was chosen as a compromise between the goals of averaging
over a sufficiently large region of the structures, and
excluding adjacent or surrounding tissue from the ROI.
Every ROI was analyzed using WCIF—Image J 1.39u
software—sWayne Rasband National Institutes of Health,
USA. This software transformed each ROI into numeric
values of fluorescence intensity per pixel. Statistical
analysis was performed using SPSS Version 15. (SPSS,
Inc., Chicago, IL), Microsoft1 Excel 2000, MicrocalTM
Origin1 software. Tests of normality were performed to
determine the choice of statistical methods. From each
structure ROI a correspondent background ROI value was
subtracted tominimize potential errors due to environment
light effects.
RESULTS
Pig Ears Microanatomy
The results of themeasurements of skin structures’ sizes
and locationare summarizedandcompared tohuman facial
skin in Figure 1. In an area of 5mm2 the average number of
HF, SG, and sweat glands were respectively about 40, 2,
and 227 in young Yorkshire pig ears; and 30, 20, and 624 in
adult Yucatan pig ears. Both adult and young pigs showed
similarmorphological structures compared to human facial
skin (Fig. 2a,b), but young pigs had somewhat slightly
smaller adnexal glands compared to adult pig and human
skin.
Fluorescence Microscopy Analysis
Fluorescence was assessed subjectively as ‘‘present’’ or
‘‘not present’’ while analyzing the digitally acquired photo-
micrographs. Baseline and control (no ALA) samples
showed weak autofluorescence of HF and stratum
corneumonly, attributedmainly to keratins but potentially
including weak fluorescence from endogenous porphyrins.
Porphyrin fluorescence was not visually apparent until
30–45 minutes after drug application and then increased
with longer periods of incubation (Fig. 3).
Fig. 1. Skin structures in young and adult pigs’ ears compared
to human facial skin. Top shows size/thickness (mm) of each
structure; bottom shows minimum, maximum, and average
location depth (mm below epidermis) of each structure. For
adult pigs, 21 hair follicles, 524 sweat glands, and 16 sebaceous
glands were analyzed. For young pigs, 22 hair follicles,
127 sweat glands, and only 3 sebaceous glands were analyzed.
For human facial skin, 3 hair follicles, 17 sweat glands, and
6 sebaceous glands were analyzed. Sweat glands in humans
are eccrine; in contrast, pigs’ ears have both eccrine and
apocrine sweat glands.
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Hair follicle and eccrine gland fluorescence began to be
visually apparent after 30 minutes, while SG fluorescence
was visually apparent beginning at 45minutes. Epidermal
fluorescence was visually greater than the baseline
epidermal autofluorescence from 30 to 45 minutes of
incubation, and was strongly visually apparent starting
at 60–90 minutes. Visually apparent fluorescence was
greatestat the longest incubation timesof135–180minutes
after ALA application at which time HF and SG fluores-
cence was apparently brighter than epidermal fluores-
cence. Quantitative analysis of porphyrin fluorescence
allowed more accurate assessment of distribution and
kinetics after ALA administration.
To confirm the assumption of normality of the results
taken from the pixel analysis of fluorescence micrographs,
we used the Kolmogorov–Smirnov (KS) test. Results
indicatedno significantdepartures fromanormal (Gaussian
shaped) distribution at any time point for sweat glands, SG,
HF, epidermis, and dermis (all P> 0.05), with the exception
of epidermis at 30 minutes which showed some evidence of
skewness (Z¼ 1.953, P¼ 0.001). Even considering this
exception, a parametric strategy was warranted and more
appropriate in this context, particularly since the vast
majority of the KS tests confirmed a normal distribution
and revealed little evidence of serious outliers or extreme
values.Therefore, parametricmethodswereapplied, includ-
ing t-tests and ANOVA (as well as regression models for
assessing time related changes in fluorescence microscopy
over time for each skin structure) (Fig. 4).
Fig. 2. Histology of adult pig ear skin, showing: a: hair follicle
(HF) and sebaceous glands (SG); b: eccrine (EG) (right) and
apocrine glands (AG) (left) at 10 (hematoxylin/eosin stain).
Opposite to human glands, pigs EG lumen are slightly larger
than AG. Note typical AG decapitation-type secretion (arrow),
producing a proteinaceous secretion.
Fig. 3. Fluorescence microscopy of young pig ear skin after
135 minutes of topical application of 20% ALA solution (10),
showing porphyrin fluorescence in epidermis (E), hair follicle
(HF), sebaceousglands (SG), andeccrine glands (EG).Contrast
was enhanced by 50% and brightness by 10% to improve
quality of the printedmaterial; these changeswere not applied
for digital image analysis.
Fig. 4. Fluorescence of epidermis, hair follicle, sebaceous
glands, sweat glands, and dermis over time, with linear fit
through the origin.
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Table 1 indicates significant increases in fluorescence
with incubation time (i.e., time since ALA application) for
all five skin structures, with fastest time-related changes
(i.e., steepest slopes) for SG and HF followed by epidermis.
Lowest correlations (i.e., significantly less time-related
changes) were observed for the dermis and sweat glands.
For all five structures, statistical analysis indicated
reasonably good linear fit (all Pearson r values are
significant, ranging from r¼ 0.36–0.90). Goodness-of-fit
F-tests all showed significant linear fit (they are all
P<0.01).
At 30minutes, EG began to show statistically significant
increase in fluorescence (P<0.00001) compared to control,
5, 10, and 15 minutes of incubation. SG showed significant
fluorescence compared to baseline starting at 60–
75 minutes of incubation (P<0.00001). In HF, porphyrin
fluorescence became significantly greater than the baseline
autofluorescence at 45 minutes after ALA application
(P<0.000001). Even though subjectively undetectable
while analyzing the digital images, quantitative pixel
analysis of the digital photomicrographs from epidermis
showed very early porphyrin accumulation after ALA.
Within 15 minutes after drug application, a statistically
significant increase in epidermal fluorescence was meas-
ured over the baseline autofluorescence (P¼ 0.04). Epider-
mal fluorescence then increased over time. Dermis showed
weak fluorescence that increased slightly with time
after ALA application. As shown in Figure 4, porphyrin
fluorescence generally increased during the entire
180 minute period of observations in this study.
DISCUSSION
The major findings of this study are: (1) the anterior
skin of porcine ears appears to be microanatomically
similar to human sebaceous facial skin, (2) porphyrins
accumulate in different skin structures at different
rates after topical application of ALA, according to
fluorescence microscopy measurements, and (3) eccrine
and apocrine glands accumulate statistically significant
levels of porphyrins after topicalALAapplication compared
to baseline.
Thefirstfinding suggests thatpig earmightbedevelopedas
amodel for sebaceous skin. Lack of an animalmodel similar
to human sebaceous skin encouraged us to closely examine
pig ear skin. Porcine skin is generally similar to human
skin [21–23], and similarly metabolizes ALA [24]. How-
ever, pigs have few and small SG over most of their body
surface. We found that both young and adult porcine
ears have skin structure, microanatomy, and morphology
similar tohuman facial skin.As inhumans, theSG inyoung
pigs are smaller than those in the adults. We also found
eccrineandapocrineglands inpig ear skin.Unlikehumans,
where apocrine gland lumens are usually 10 times larger
than eccrine glands [25], pig ears have apocrine glands
somewhat smaller than the eccrine glands. In addition,
human facial skin rarely contains apocrine glands [25].
Both types of sweat glands are numerous in pig ears, and
located close toHF. The anterior (inner) surface of adult pig
ears appears to be a good animal model for adnexal glands.
The second finding suggests that different skin struc-
tures may be preferentially affected by ALA-PDT depend-
ing on the time between ALA application and light
exposure. Specifically, the earliest porphyrin accumulation
is in epidermis, followed by eccrine and apocrine glands,
thenHFandSG,untilmaximumlevels are reached in these
structures over a 3-hour period. Three hours was the
longest time period of application studied. Light exposure
3 hours after application of ALA under occlusion is likely to
affect all of these structures.For thepurpose ofALA-PDTto
target SG, this study suggests that a long incubation time is
needed, after which epidermis and other glands will also be
affected.
It is possible that porphyrins levels might accumulate
further after longer application times since according to
Figure 4 there is no evidence of fluorescence levels reaching
a plateau. Since Kennedy et al.’s initial report [5], ALA-
PDT has become a popular therapeutic method in derma-
tology. Various indications and different protocols for
treatments have been reported. To date, there is no real
consensus about the incubation time after ALA application
needed to allow accumulation of sufficient PS before light
irradiation. FollowingHongcharu et al.’s initial report [4] of
TABLE 1. Statistical Summary of Corrected Fluorescence Results for Each Skin
Structure*
Pearson r R-squared P-value
Slope (increase/
minute)
Sweat glands 0.36 0.13 <0.01 0.20
Sebaceous glands 0.90 0.81 <0.001 0.77
Hair follicles 0.70 0.49 <0.001 0.40
Epidermis 0.81 0.66 <0.001 0.38
Dermis 0.55 0.30 <0.01 0.05
*Regression analysis indicated that each skin structure showed a significant linear increase in
fluorescence pixel analysis over the 180-minute incubation period. The slopes represent the
estimated increase in fluorescence per minute with significantly steeper slopes for sebaceous
glands and hair follicles compared to sweat glands and dermis (P< 0.001).
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long-lasting efficacy for acne treatment in a prospective,
controlled study using high-fluence red light given 3 hours
afterALAapplicationunder occlusion, several studieswere
reported using different incubation times from 15 minutes
[12] to 4 hours [13,26] after ALAapplication. Awide variety
of blue, yellow, and red light sources and treatment
fluences have also been used. Another confounding factor
is that unintentional exposure to environmental light
sources such as sunlight,may in practice play a therapeutic
role [27]. Methyl-ALA, which is rapidly converted to ALA
after uptake into skin, has been developed and studied as
an alternative to topical ALA. The efficacy of topical
methyl-ALA for acne therapy is apparently similar to that
of topical ALA, when used with long application time and
high fluences of red light.
This study has several limitations. It is difficult to
absolutely quantify porphyrins by fluorescence microscopy,
due to variations in frozen section thickness, porphyrin
photobleaching during sample processing and imaging, and
in theory, site-dependent quenching of porphyrin fluores-
cence due to various microenvironments in the tissue. We
compensated for baseline tissue autofluorescence and for
background light levels in the image analysis. However,
other sources of variability exist thatwere not compensated.
These include random variations in frozen section thickness
(nominally 15 mm), random variations in the amount of
porphyrin photobleaching during tissue handling and
microscopy, potential diffusion of porphyrins between
structures in the sections, and optical scattering of fluo-
rescence emission during imaging. Dermal fluorescence in
many individual tissue sections was noted to correspond
with the presence of brightly fluorescent follicles, glands or
epidermis in the particular sample. This suggests that at
least part of theweakdermalfluorescencenoted inour study
is an artifact, for example, due to porphyrin leakage from
adjacent structures in the section, and/or due to optical
scattering within the sample. Several different fluorescent
porphyrin species may also be present, and we did not
attempt to isolate them. For these reasons, the study
provides semi-quantitative relative values rather than an
absolute analysis of porphyrin concentration among the
various skin structures.
Sampling errors can also occur. Due to the smaller size of
SG in the young pigs, detection of SG with weak
fluorescence after short periods of incubation was more
difficult and could have created a negative bias in our
analysis. Another potential source for error in this study
was difficulty identifying non-fluorescent structures at the
early times after ALA application.While epidermis andHF
are readily seen in the absence of any tissue stain, it can be
difficult to find glands. A potential bias therefore exists by
omitting individual non-fluorescent structures from the
analysis, simply by failing to find them. Finally, selective
targeting of skin structures depends on other variables
other than the time of incubation. Statistically significant
fluorescence does not necessarily equate to adequate
porphyrin levels for a photodynamic response, but lack of
fluorescence during early periods after ALA application
strongly suggests that early periods may not produce
sufficient porphyrin levels. The third finding suggests that
some eccrine and/or apocrine gland disorders may be
treatable with ALA-PDT. For example, hydradenitis
suppurativa is a painful, inflammatory and scarring
condition of the groin and/or axillae that is associated with
both sebaceous and apocrine gland occlusion. Cases of this
condition have been anecdotally reported to respond to
ALA-PDT [28]. To the best of our knowledge, eccrine or
apocrine gland-targetedPDT isanovel observation forALA
or any other PS. While eccrine gland function for thermo-
regulation is well known, the function(s) of apocrine glands
is unclear andmaybe related to scent. In humans, bacterial
metabolism of apocrine sweat is largely responsible for
axillary odor. Apocrine sweat is formed by ‘‘decapitation’’ of
cellular cytoplasm, when the apical portion of the secretory
cell cytoplasm is eliminated into the lumen of the gland as
shown in Figure 2b, producing a proteinaceous secretion
(mostly sialomucin) [25]. In contrast, SG shed cells that
have synthesized a mixture of lipids and wax esters, to
produce sebum. The pathway(s) by which ALA reaches
these three secretory glands in skin following topical
application have not been determined. The secretory coils
of eccrine and apocrine glands are very deep structures.
The rapid appearance of porphyrin fluorescence suggests
that direct uptake of ALA may be occurring through the
ducts that communicate with the skin surface. This
hypothesis deserves further testing; manipulation of
the ALA solution vehicle could potentially optimize such
uptake. In this limited study, only one ALA vehicle
(ethanol/water) was tested. After penetration by whatever
route(s), ALA is taken up by cells and metabolized to the
coproporphyrinogen, a precursor of heme, which is then
taken up by mitochondria via peripheral benzodiazepine
receptors [29].
In summary, it is clear that topical 20% ALA
induces early epidermal porphyrin synthesis, followed by
progressive time-dependent and strong fluorescent por-
phyrin accumulations in epidermis, eccrine and apocrine
glands, HF epithelium, and SG. There is weak fluorescent
porphyrin accumulation in the dermis, and nonewas noted
in subcutaneous fat following topical ALA. These findings
suggest that topical ALA-PDT of epidermal targets
may require relatively short application times, for example,
15–30 minutes. For SG targeting in this animal model, an
application time of at least 45–60 minutes appears to be
needed. In this study, we show that pig ear skin is largely
anatomically similar to human sebaceous skin, but we
did not study functional aspects such as sebum output,
response to hormones, secretory stimuli, or follicular
occlusion, for example. Development of pig ear as a
functionalmodel deserves further study.We aim to develop
and utilize this model for studying ALA-PDT of sebaceous,
eccrine and apocrine structures, and for further compar-
ison with human skin.
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